Aurinia Pharmaceuticals Inc.AUPHNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average, structural decline.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-4.69M
↑ 94% above average
Average (9y)
$-73.34M
Historical baseline
Range
High:$-4.69M
Low:$-180.74M
CAGR
-16.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-4.69M | +94.9% |
| 2023 | $-91.69M | +17.7% |
| 2022 | $-111.47M | +38.3% |
| 2021 | $-180.74M | -73.3% |
| 2020 | $-104.29M | -14.7% |
| 2019 | $-90.94M | -61.9% |
| 2018 | $-56.16M | -19.3% |
| 2017 | $-47.06M | -106.3% |
| 2016 | $-22.81M | +3.2% |
| 2015 | $-23.58M | - |